Experimental Hepatorenal Syndrome Drug Gets Orphan Drug Designation
stevepb / Pixabay

Experimental Hepatorenal Syndrome Drug Gets Orphan Drug Designation

According to a story from accesswire.com, the drug developer BioVie, Inc., recently announced that the US Food and Drug Administration (FDA) has granted Orphan Drug designation to the company's investigational…

Continue Reading Experimental Hepatorenal Syndrome Drug Gets Orphan Drug Designation
Close Menu